Bayer Healthcare in $97.5 million kickback settlement
WASHINGTON (Reuters) - Diabetic supply maker Bayer Healthcare, a unit of Bayer AG, has agreed to pay $97.5 million to settle allegations that it paid kickbacks to several diabetic suppliers and caused them to submit false Medicare claims, the U.S. Justice Department said on Tuesday.
Bayer agreed to enter into a corporate integrity agreement - which allows companies to continue in the federal Medicare program while requiring steps to safeguard against fraudulent behavior - as part of the settlement, the department said.
The settlement resolves allegations that Bayer paid 11 diabetic suppliers to convert their patients to Bayer products from competitors’ products. It pertains to Medicare claims submitted by the companies from 1998 to 2007.
The department said Bayer allegedly paid Liberty Medical Supply Inc about $2.5 million between 1998 and 2002 to convert its patients to Bayer. It also allegedly paid kickbacks of about 375,000 to 10 other diabetic suppliers.
“Paying healthcare suppliers to place a particular brand of device with Medicare beneficiaries violates the law and will not be tolerated,” said Gregory Katsas, assistant attorney general for the department’s civil division.
--------------------------------------------------------------------------------------------Related Posts:
CHICAGO (Reuters) - Airborne Health Inc has agreed to pay $7 million to settle investigations by 32 state attorneys general and the District of Columbia over the past marketing and labeling of its products. Airborne did not admit any wrongdoing in the settlement. It previously settled two matters involving similar claims. The privately held company makes popular
Full Post: Airborne pays $7 mln in settlement with 32 states
--------------------------------------------------------------------------------------------
BOSTON (Reuters) - Bristol-Myers Squibb Co said on Tuesday it agreed to pay $1.1 million to settle charges connected with an anti-trust investigation by the New York State Attorney General’s Office, Last year, Bristol-Myers pleaded guilty to two federal criminal counts related to allegations that it illegally concealed a side deal with the generic drugmaker Apotex
Full Post: Bristol-Myers settles Plavix case with states
--------------------------------------------------------------------------------------------
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - Americans spent $2.2 trillion on healthcare in 2007, or $7,421 per person, according to a U.S. government report released on Tuesday. The 6.1 percent rate of growth over 2006 was the lowest since 1998, mostly because growth in spending on drugs slowed, the team at the Centers
Full Post: U.S. health spending hits $2.2 trillion in 2007
--------------------------------------------------------------------------------------------
By Susan Heavey WASHINGTON (Reuters) - Democratic lawmakers are expanding a probe into direct-to-consumer drug advertisements to include Bayer AG’s combination aspirin product, according to letters released on Tuesday. Bayer’s marketing of its Aspirin with Heart Advantage, a combination product that includes a dietary supplement, appears to go against a U.S. Food and Drug Administration request not
Full Post: Lawmakers question ads for Bayer “herbal” aspirin
--------------------------------------------------------------------------------------------
WASHINGTON (Reuters) - U.S. health officials proposed paying for wider use of PET scans to help doctors decide the initial course of treatment in some cancer patients, the Centers for Medicare & Medicaid Services said on Tuesday. CMS said in a draft proposal that it would allow most Medicare patients to undergo one positron emission tomography
Full Post: Medicare proposes wider cancer scan coverage